# A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

> **NCT00945672** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **BIOLOGICAL:** PF-04360365 10 mg/kg
- **BIOLOGICAL:** PF-04360365 7.5 mg/kg
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00945672
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-06
- **Primary completion:** 2011-06-01
- **Final completion:** 2011-06-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945672, "A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00945672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*